Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Public ClinicalTrials.gov record NCT06943755. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2/3, Multicenter, Randomized Open-Label Study of Zanzalintinib vs Everolimus in Participants With Previously Treated, Unresectable, Locally Advanced or Metastatic Neuroendocrine Tumors
Study identification
- NCT ID
- NCT06943755
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Exelixis
- Industry
- Enrollment
- 440 participants
Conditions and interventions
Interventions
- Everolimus Drug
- Zanzalintinib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 20, 2025
- Primary completion
- May 31, 2029
- Completion
- May 31, 2029
- Last update posted
- Apr 16, 2026
2025 – 2029
United States locations
- U.S. sites
- 39
- U.S. states
- 25
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Exelixis Clinical Site #43 | Birmingham | Alabama | 35294 | Recruiting |
| Exelixis Clinical Site #36 | Phoenix | Arizona | 85054 | Recruiting |
| Exelixis Clinical Site #42 | Tucson | Arizona | 85724 | Recruiting |
| Exelixis Clinical Site #18 | Beverly Hills | California | 90211 | Recruiting |
| Exelixis Clinical Site #16 | Los Angeles | California | 90033 | Recruiting |
| Exelixis Clinical Site #54 | Palo Alto | California | 94305 | Recruiting |
| Exelixis Clinical Site #12 | Santa Monica | California | 90404 | Recruiting |
| Exelixis Clinical Site #29 | Vallejo | California | 94589 | Recruiting |
| Exelixis Clinical Site #19 | Washington D.C. | District of Columbia | 20007 | Recruiting |
| Exelixis Clinical Site #35 | Jacksonville | Florida | 32224 | Recruiting |
| Exelixis Clinical Site #11 | Tampa | Florida | 33612 | Recruiting |
| Exelixis Clinical Site #9 | Lexington | Kentucky | 40536 | Recruiting |
| Exelixis Clinical Site #23 | Metairie | Louisiana | 70006 | Recruiting |
| Exelixis Clinical Site #8 | Boston | Massachusetts | 02215 | Recruiting |
| Exelixis Clinical Site #47 | Detroit | Michigan | 48202 | Recruiting |
| Exelixis Clinical Site #1 | Grand Rapids | Michigan | 49546 | Recruiting |
| Exelixis Clinical Site #38 | Rochester | Minnesota | 55905 | Recruiting |
| Exelixis Clinical Site #5 | St Louis | Missouri | 63110 | Recruiting |
| Exelixis Clinical Site #25 | Omaha | Nebraska | 68198 | Recruiting |
| Exelixis Clinical Site #14 | Albuquerque | New Mexico | 87131 | Recruiting |
| Exelixis Clinical Site #59 | Buffalo | New York | 14263 | Recruiting |
| Exelixis Clinical Site #7 | New York | New York | 10029 | Recruiting |
| Exelixis Clinical Site #53 | Rochester | New York | 14642 | Recruiting |
| Exelixis Clinical Site #17 | Chapel Hill | North Carolina | 27599 | Recruiting |
| Exelixis Clinical Site #6 | Durham | North Carolina | 27710 | Recruiting |
| Exelixis Clinical Site #57 | Fargo | North Dakota | 58102 | Recruiting |
| Exelixis Clinical Site #39 | Cleveland | Ohio | 44106 | Recruiting |
| Exelixis Clinical Site #28 | Columbus | Ohio | 43221 | Recruiting |
| Exelixis Clinical Site #27 | Portland | Oregon | 97210 | Recruiting |
| Exelixis Clinical Site #20 | Philadelphia | Pennsylvania | 19104 | Recruiting |
| Exelixis Clinical Site #21 | Pittsburgh | Pennsylvania | 15232 | Recruiting |
| Exelixis Clinical Site #24 | Knoxville | Tennessee | 37920 | Recruiting |
| Exelixis Clinical Site #65 | Nashville | Tennessee | 37232 | Recruiting |
| Exelixis Clinical Site #10 | Dallas | Texas | 75264 | Recruiting |
| Exelixis Clinical Site #15 | Salt Lake City | Utah | 84112 | Recruiting |
| Exelixis Clinical Site #3 | Charlottesville | Virginia | 22903 | Recruiting |
| Exelixis Clinical Site #13 | Fairfax | Virginia | 22031 | Recruiting |
| Exelixis Clinical Site #34 | Seattle | Washington | 98109 | Recruiting |
| Exelixis Clinical Site #31 | Milwaukee | Wisconsin | 53226 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06943755, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 16, 2026 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06943755 live on ClinicalTrials.gov.